Trial NCT03628391

View at ClinicalTrials.gov 
Org. Study IDs: MEC-2017-115/NL62689.078.17

Last trial update was posted on 2022-05-11

MeSH Interventions

Haloperidol Haloperidol decanoate

MeSH Conditions

Cognitive Dysfunction Critical Illness Delirium

Other Conditions

Cognitive Decline Cognitive Impairment Intensive Care Psychosis

Stopping Reasons

The study was stopped because of futility of being able to reach a one-day difference between treatment groups in the primary outcome of DCFD in the intended sample size.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID